Search For "gilead"
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per via
Updated : 5 years, 10 months ago IST
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Read More
Gilead Sciences to start trials of inhaled version of remdesivir
Updated : 5 years, 11 months ago IST
California [USA], June 23 (ANI): US-based biopharmaceutical major Gilead Sciences will soon start clinical trials for inhaled formulation of its anti-viral drug remdesivir used for the treatment of Covid-19.
Read More
Six Indian companies applied to CDSCO for permission to manufacture, marke
Updated : 5 years, 11 months ago IST
New Delhi [India], June 14 (ANI): The Centre on Sunday said that six Indian companies -- Hetero, Cipla, BDR, Jubilant, Mylan and Dr Reddy's Labs -- have applied to Indian Drug Regulatory Agency, Central Drug Standard Control Organisation (CDSCO) for permission to manufacture and market the R
Read More
Dr Reddy's Labs in licensing pact with Gilead Sciences for Remdesivir
Updated : 5 years, 11 months ago IST
Hyderabad (Telangana) [India], June 13 (ANI): Dr Reddy's Laboratories said on Saturday it has entered into a non-exclusive licensing agreement with Gilead Sciences Inc that will grant Dr Reddy's the right to register, manufacture and sell Gilead's investigational drug Remdesivir, a potent
Read More
Zydus signs licensing agreement with Gilead to manufacture and market Remd
Updated : 5 years, 11 months ago IST
Ahmedabad (Gujarat) [India], June 13 (ANI): Healthcare major Zydus Cadila has signed a non-exclusive licensing agreement with Gilead Sciences Inc for the manufacturing and distribution of Remdesivir, the investigational drug which has been issued an emergency use authorisation by the US Food
Read More
'US' current supply of Remdesivir to get exhausted by end of June'
Updated : 5 years, 11 months ago IST
Washington DC [USA], June 8 (ANI): The US government's current supply of Remdesivir, the only drug till now known to be working against coronavirus, will exhaust by the end of June.
Read More
COVID-19: Remdesivir gets nod from CDCSO for 'restricted emergency use' on
Updated : 5 years, 11 months ago IST
New Delhi [India], June 2 (ANI): In a significant development, the country's top drug controller the Central Drug Control Standard Organisation (CDCSO) has given permission to Gilead Sciences for marketing authorization of its anti-viral drug Remdesivir "only for restricted emergency use" o
Read More
Coronavirus: Too early to discuss pricing of remdesivir, says US' Departme
Updated : 5 years, 12 months ago IST
Washington DC [USA], May 28 (ANI): The Department of Health and Human Services has said that it is too early to discuss the pricing of 'remdesivir', the drug which has raised everyone's hopes of treating the coronavirus.
Read More
Jubilant Life Sciences surges 5 pc after signing deal with Gilead for prod
Updated : 6 years ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): The share price of Jubilant Life Sciences surged 5 per cent hitting upper circuit of Rs 429.95 per share on Wednesday after the company signed a deal with US-based Gilead Sciences Inc for production of Remdesivir to fight COVID-19.
Read More
COVID-19: Cipla enters into licensing pact with Gilead to manufacture and
Updated : 6 years ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): Pharmaceutical major Cipla said on Wednesday it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distributing investigational medicine Remdesivir which has been issued an emergency use authorisation by t
Read More
Gilead in talks with Indian drugmakers to produce remdesivir for treatment
Updated : 6 years ago IST
New Delhi [India], May 6 (ANI): US-based biopharmaceutical major Gilead Sciences said on Wednesday it is negotiating long-term voluntary licences with several generic drugmakers in India to produce remdesivir for developing countries.
Read More
India can easily do synthesis of antiviral drug - Remdesivir: Former ICMR
Updated : 6 years ago IST
New Delhi [India], May 3 (ANI): India can easily do the synthesis of antiviral drug - Remdesivir - if allowed by the US-based pharma major Gilead Sciences, said Dr Nirmal K Ganguly, former Director-General, Indian Council of Medical Research (ICMR), on Saturday.
Read More